Cyclacel Pharmaceuticals
CYCC
CYCC
25 hedge funds and large institutions have $1.29M invested in Cyclacel Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 3 closing their positions.
Holders
25
Holders Change
-2
Holders Change %
-7.41%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
8
Closed
3
Calls
$14K
Puts
–
Net Calls
+$14K
Net Calls Change
+$2K
Top Buyers
Top Sellers
1 |
1
Millennium Management
New York
|
$68K |
2 |
SSA
2
Schonfeld Strategic Advisors
New York
|
$420K |
3 |
E
3
Ergoteles
New York
|
$0 |
4 |
VF
4
Virtu Financial
New York
|
$0 |
5 |
HF
5
HRT Financial
New York
|
$12K |